Showing results (271-280 of 292) with videos related to

Sort By:
Pageof 30
Alzheimer'S Research & Therapy|May 6, 2017
Communicating mild cognitive impairment diagnoses with and without amyloid imagingJoshua D Grill, Liana G Apostolova, Szofia Bullain, et al.
Acta Neuropathologica|March 17, 2010
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairmentWilliam T Hu, Alice Chen-Plotkin, Steven E Arnold, et al.
JAMA Network Open|March 30, 2026
Amyloid Imaging and APOE Genotype Disclosure and Short-Term Psychological DistressJoshua D Grill, Rema Raman, Shunran Wang, et al.
JAMA Internal Medicine|September 20, 2021
Effectiveness and Ethics of Incentives for Research Participation: 2 Randomized Clinical TrialsScott D Halpern, Marzana Chowdhury, Brian Bayes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 18, 2025
Evaluation of self-mediated alternatives for risk testing education and return of results (eSMARTER) study: A randomized study of methods for returning APOE and pTau-217 resultsClaire M Erickson, Carolyn M Langlois, Elisabeth McCarty Wood, et al.
JAMA Network Open|July 29, 2021
Patient Preference and Risk Assessment in Opioid Prescribing Disparities: A Secondary Analysis of a Randomized Clinical TrialEden Engel-Rebitzer, Abby R Dolan, Shoshana V Aronowitz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2024
Artificial Intelligence and Technology Collaboratories: Innovating aging research and Alzheimer's carePeter Abadir, Esther Oh, Rama Chellappa, et al.
Contemporary Clinical Trials|November 12, 2018
Randomized evaluation of trial acceptability by INcentive (RETAIN): Study protocol for two embedded randomized controlled trialsDustin C Krutsinger, Jacqueline McMahon, Alisa J Stephens-Shields, et al.
Neurobiology of Disease|December 19, 2006
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcriptsAmanda J Myers, Alan M Pittman, Alice S Zhao, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 27, 2020
Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairmentKurt D Christensen, Jason Karlawish, J Scott Roberts, et al.
Pageof 30